Traitement initial des cancers épithéliaux de l'ovaire de stade avancé

Philippe Morice; Sophie Camatte; Catherine Lhomme; Pierre Duvillard; Damienne Castaigne

Traitement initial des cancers épithéliaux de l'ovaire de stade avancé

Philippe Morice, Sophie Camatte, Catherine Lhomme, Pierre Duvillard, Damienne Castaigne

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

3 Citations (Scopus)

Résumé

The management of advanced stage ovarian cancer was deeply modified during last years. The standard treatment of advanced stage ovarian cancer in 2004 remains the initial surgery (in order to obtain ideally a total resection of all macroscopic disease) followed by adjuvant chemotherapy (6 courses of platinum based chemotherapy). But in patients with massive spread, interval debulking surgery (performed after 3 or 4 courses of neo-adjuvant chemotherapy) is becoming an interesting option (and perhaps will become a standard management). This treatment is actually studied in randomized trials.

Titre traduit de la contribution	Management of advanced stage ovarian cancer
langue originale	Français
Pages (de - à)	1777-1786
Nombre de pages	10
journal	Revue du Praticien
Volume	54
Numéro de publication	16
état	Publié - 31 oct. 2004

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{f20358ee75d848efbc737bbacc1d287f,

title = "Traitement initial des cancers {\'e}pith{\'e}liaux de l'ovaire de stade avanc{\'e}",

abstract = "The management of advanced stage ovarian cancer was deeply modified during last years. The standard treatment of advanced stage ovarian cancer in 2004 remains the initial surgery (in order to obtain ideally a total resection of all macroscopic disease) followed by adjuvant chemotherapy (6 courses of platinum based chemotherapy). But in patients with massive spread, interval debulking surgery (performed after 3 or 4 courses of neo-adjuvant chemotherapy) is becoming an interesting option (and perhaps will become a standard management). This treatment is actually studied in randomized trials.",

author = "Philippe Morice and Sophie Camatte and Catherine Lhomme and Pierre Duvillard and Damienne Castaigne",

year = "2004",

month = oct,

day = "31",

language = "Fran{\c c}ais",

volume = "54",

pages = "1777--1786",

journal = "Revue du Praticien",

issn = "0035-2640",

number = "16",

}

TY - JOUR

T1 - Traitement initial des cancers épithéliaux de l'ovaire de stade avancé

AU - Morice, Philippe

AU - Camatte, Sophie

AU - Lhomme, Catherine

AU - Duvillard, Pierre

AU - Castaigne, Damienne

PY - 2004/10/31

Y1 - 2004/10/31

N2 - The management of advanced stage ovarian cancer was deeply modified during last years. The standard treatment of advanced stage ovarian cancer in 2004 remains the initial surgery (in order to obtain ideally a total resection of all macroscopic disease) followed by adjuvant chemotherapy (6 courses of platinum based chemotherapy). But in patients with massive spread, interval debulking surgery (performed after 3 or 4 courses of neo-adjuvant chemotherapy) is becoming an interesting option (and perhaps will become a standard management). This treatment is actually studied in randomized trials.

AB - The management of advanced stage ovarian cancer was deeply modified during last years. The standard treatment of advanced stage ovarian cancer in 2004 remains the initial surgery (in order to obtain ideally a total resection of all macroscopic disease) followed by adjuvant chemotherapy (6 courses of platinum based chemotherapy). But in patients with massive spread, interval debulking surgery (performed after 3 or 4 courses of neo-adjuvant chemotherapy) is becoming an interesting option (and perhaps will become a standard management). This treatment is actually studied in randomized trials.

UR - http://www.scopus.com/inward/record.url?scp=8144220663&partnerID=8YFLogxK

M3 - Article 'review'

C2 - 15630882

AN - SCOPUS:8144220663

SN - 0035-2640

VL - 54

SP - 1777

EP - 1786

JO - Revue du Praticien

JF - Revue du Praticien

IS - 16

ER -